Abstract:Background: Neuroinflammation, which is mainly mediated by excessive microglia activation, plays a major role in ischemic stroke. Overactivated microglia secrete numerous inflammatory cytokines, causing excessive inflammatory responses and ultimately exacerbating ischemic brain injury. Hence, compounds that attenuate neuroinflammation could become promising drug candidates for ischemic stroke. Fraxetin has an anti-inflammatory effect in many inflammatory diseases. However, whether it possesses an anti-inflammatory capacity in microglia-mediated neuroinflammation after ischemic brain injury is unknown. Our study aimed to investigate the suppression effect of fraxetin on neuroinflammation in lipopolysaccharide (LPS)-activated microglia and establish whether fraxetin could alleviate ischemic brain injury in a rodent model of ischemic stroke.Methods: For the in vitro experiment, primary microglia were obtained from 1-day-old C57/BL6J mice. The cells were activated with LPS and treated with fraxetin at a non-cytotoxic concentration. Real-time PCR, enzyme-linked immunosorbent assays, and immunofluorescence staining were used to evaluate the anti-inflammatory effects of fraxetin. The potential molecular mechanisms were explored and verified through RNA-sequencing analysis, western blotting and real-time PCR. For the in vivo experiment, focal ischemia was induced by middle cerebral artery occlusion (MCAO) in 8-week-old male C57/BL6J mice. Fraxetin (5 mg/kg) or an equal volume of saline was injected into mice intraperitoneally after MCAO, and 2% 2,3,5-triphenyltetrazolium chloride staining was applied to measure infarct volume. Behavioral tests were conducted to measure neurological deficits in the mice. Real-time PCR, western blotting, and immunofluorescence staining were used to examine the expression of inflammatory cytokines and microglia activation in the ischemic penumbra.Results: Fraxetin effectively inhibited the expression of proinflammatory cytokines including inducible nitric oxide synthase, tumor necrosis factor-α, interleukin-1 beta, and interleukin-6 in LPS-activated microglia. Fraxetin also suppressed the PI3K/Akt/NF-κB signaling pathway in activated microglia, which contributed to its anti-inflammatory effects. Furthermore, the administration of fraxetin attenuated ischemic brain injury and behavioral deficits after stroke. Finally, fraxetin was found to attenuate the activation of microglia both in vitro and in vivo.Conclusions: Our results suggest that fraxetin has a suppression effect on microglia-mediated neuroinflammation, and this effect is associated with the PI3K/Akt/NF-κB signaling pathway. Fraxetin may therefore have potential neuroprotective properties for ischemic stroke.

Fraxin inhibits lipopolysaccharide-induced inflammatory cytokines and protects against endotoxic shock in mice.

Fraxin Ameliorates Lipopolysaccharide-Induced Acute Lung Injury in Mice by Inhibiting the NF-κB and NLRP3 Signalling Pathways.

Protective effects of fraxin on cerebral ischemia-reperfusion injury by mediating neuroinflammation and oxidative stress through PPAR-γ/NF-κB pathway

Protective Effects of Isofraxidin Against Lipopolysaccharide-Induced Acute Lung Injury in Mice.

Isofraxidin Protects Mice from LPS Challenge by Inhibiting Pro-Inflammatory Cytokines and Alleviating Histopathological Changes.

Fraxetin alleviates microglia-mediated neuroinflammation after ischemic stroke

Hepatoprotective Effect of Fraxin Against Carbon Tetrachloride-Induced Hepatotoxicity in Vitro and in Vivo Through Regulating Hepatic Antioxidant, Inflammation Response and the MAPK-NF-κB Signaling Pathway

Suppression of NF-κB Signaling and NLRP3 Inflammasome Activation in Macrophages is Responsible for the Amelioration of Experimental Murine Colitis by the Natural Compound Fraxinellone

Fraxin (7-hydroxy-6-methoxycoumarin 8-glucoside) confers protection against ionizing radiation-induced intestinal epithelial injury in vitro and in vivo

Fraxin Prevents Chemically Induced Hepatotoxicity by Reducing Oxidative Stress

Fraxetin Ameliorates Symptoms of Dextran Sulphate Sodium-Induced Colitis in Mice

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.

Fraxin Represses NF-κB Pathway Via Inhibiting the Activation of Epidermal Growth Factor Receptor to Ameliorate Diabetic Renal Tubulointerstitial Fibrosis.

Fraxinellone protects against cardiac injury and decreases ventricular fibrillation susceptibility during myocardial ischemia-reperfusion

7-Hydroxy-6-methoxycoumarin 8-Glucoside (fraxin) Confers Protection Against Ionizing Radiation-Induced Intestinal Epithelial Cell Death Both in Vitro and in Vivo.

Isofraxidin Exhibited Anti-Inflammatory Effects in Vivo and Inhibited TNF-α Production in LPS-induced Mouse Peritoneal Macrophages in Vitro Via the MAPK Pathway

[Effect of Dexamethasone on Expression of Fractalkine in Lipopolysaccharide-Induced Acute Lung Injury].

Natural compound fraxinellone ameliorates intestinal fibrosis in mice via direct intervention of HSP47-collagen interaction in the epithelium

Xanthohumol Ameliorates Lipopolysaccharide (Lps)-Induced Acute Lung Injury Via Induction of AMPK/GSK3β-Nrf2 Signal Axis.

Xanthoxylin Attenuates Lipopolysaccharide-Induced Lung Injury through Modulation of Akt/HIF-1α/NF-κB and Nrf2 Pathways